SIRION Biotech is the leading European developer of viral vectors for gene and cell therapy applications. Founded in 2006, SIRION Biotech currently employs more than 60 people of about 17 nationalities, mostly at our main locations near Munich, but also in our other sites in Heidelberg, Paris, and Boston. Since September 2021, SIRION Biotech has been part of revvity (formerly PerkinElmer), an international leader in the field of medical and biotechnology.